Smart science to improve lives™
0 View basket

Explore our latest available downloads...

Explore Croda Pharmas resource area

Excipients in parenteral drug delivery - Injectable delivery of Small Molecules

Discover our latest literature highlighting our high purity excipients used in the parenteral delivery of small molecule drugs. Included in our latest brochure are our lipid offerings.

Lipids play a pivotal role in enhancing the parenteral delivery of small molecule APIs by facilitating the formation of liposomes while Liposomes provide a stable and biocompatible carrier system for the encapsulation and solubilization of both hydrophobic and hydrophilic drug compounds.

This unique capability not only improves the drug's bioavailability but also ensures a controlled and sustained release, optimising therapeutic outcomes. Liposomal drug delivery has shown proven efficacy in various small molecule applications, including: pain management drugs, cancer therapies and more...

The ability of liposomes to encapsulate drugs makes them an ideal choice for targeted delivery, addressing the specific challenges associated with these critical therapeutic areas. Our commitment to advancing cutting edge science supports the development of medicines, empowering formulators with reliable solutions for developing next-generation therapies

Injectable delivery of small molecules

Cover of flyer from Croda Pharma: Injectable delivery of small molecules
Flyer 179.9 KB

Vaccines for a more sustainable future whitepaper

Confronting the challenge and impact of climate change is all around us and it's equally important that this is considered when in the development of novel vaccines. If we continually tap into nature’s resources in an unsustainable way, we will inevitably run out.
 
We can all contribute to not only select sustainable ingredients, but to secure supply chains and sources that will not deplete in the future. We discuss this in our latest white paper: Vaccines for a more sustainable future.

We must take every possible step to safeguard our planet as we strive for a sustainable future. A nature-positive approach empowers our planet and communities. It's a revolutionary concept that challenges us to reimagine our role on Earth, by acting to positively impact biodiversity and the natural environment.
 
Yet, confronting this challenge isn't limited to only addressing climate issues; we must extend our efforts to embrace and protect nature as well.

Whitepaper: Vaccines for a more sustainable future

Cover of Vaccines for a more sustainable future whitepaper from Croda Pharma
692.3 KB

recent insights:

Blue washed image of female in lab

A proven foundation: the history of aluminium adjuvants

Vaccine developers today have access to an expanding range of adjuvant technologies. However, aluminium-based adjuvants remain some of the most established and widely used ingredients for vaccine...
GLP1 Injection being administered to stomach

Formulation challenges in GLP-1 therapeutics: Why excipient purity matters

GLP-1-based peptide therapeutics are transforming the treatment of obesity and type 2 diabetes. As developers race to advance the next generation of these medicines, formulation scientists face a less...
Test Image

One month countdown until CPHI Europe

In a month’s time, over 20 colleagues spanning sales, marketing, R&D and sustainability will be amongst the action at CPHI Europe 2026 in Milan – one of the most important events in the pharmaceutical...